Gilead Sciences | The Together Campaign
Together, we can help end the HIV epidemic for everyone, everywhere
Open To All & Gilead HIV
Meet the people who make our shared vision possible.
Barbershop Talk & Gilead HIV
Hand in Hand with Mexico & Gilead HIV
Hope for Senegal & Gilead HIV
Zero Hour™ Podcast
Hosted by Gilead employees Dr. Chauncey Watson and Dr. David Malebranche, Zero Hour™ explores HIV and health through candid conversations with global health experts, activists, and changemakers.
Listen and subscribe on all major podcast platforms or watch on YouTube. Episodes available biweekly as of May 2023.
Ending the epidemic for everyone, everywhere
Decades of scientific innovation, partnership, and advocacy helped transform HIV from a fatal diagnosis to one that could be managed and prevented. Now, we’ll continue to support the wellness of all people impacted by HIV until the virus is eliminated.
Developing innovations
We developed the first HIV single tablet regimen and the first oral therapy to prevent HIV, but we’re still researching new strategies.
Advancing equitable care
We’re committed to inclusive science, meaning our research and partnerships expand worldwide so everyone has access to proper care.
Transformative collaboration
Pervasive prejudice perpetuates stigma surrounding HIV. We’re working closely with communities to fight discrimination.
Gilead’s commitment to ending the epidemic
Where we’ve been
Gilead created the first single-tablet HIV treatment and the first medicines to reduce the risk of infection.1 Gilead is proud to be recognized as the largest private funder of non-profit HIV programs in the U.S., and third largest in the world to date.2
1 gilead.com/news-and-press/
Where we are
We’ve been teaming up with organizations to improve care globally. We’ve launched initiatives like COMPASS, RADIAN®, and Zeroing In™, while growing existing programs like AIDSVu. We are even raising awareness of HIV in Japan with a comic book.
Where we’re headed
We are fully committed to supporting people and communities impacted by HIV. We continue to fight day in and day out to end the epidemic, with the goal of achieving a functional cure for HIV.
Voices of Global Health Equity
No Barrier Left Unbroken: Ensuring Health Equity for All
Our vision at Gilead is to ensure worldwide access to equitable care. This starts with understanding the unique barriers that keep people from meaningful, life-changing care. Together with global health experts, we’re reaching across cultures, languages and communities to make sure we end the HIV epidemic for everyone, everywhere.
Product Innovation
Gilead is committed to advancing care for patients around the world by bringing forward medicines in areas of unmet medical need. We do this through internal research and development, as well as through collaborations with academic and industry partners.